Skip to main content

2022 | OriginalPaper | Buchkapitel

9. Probiotics for Atopic Dermatitis: An Update

verfasst von : Pratik Kakade, Sarika Wairkar, Shruti Lohakare, Purav Shah, Vandana Patravale

Erschienen in: Probiotic Research in Therapeutics

Verlag: Springer Singapore

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Atopic dermatitis (AD) is a chronic, inflammatory disorder associated with dry, scaly, and extremely itchy skin having complex pathophysiology. Mostly, symptomatic treatments are offered to AD that include skin moisturizers, antihistaminic, topical steroids, etc. Although exact pathophysiology of AD is not clear, it was reported that along with genetic factors, epidermis dysfunction, and immune system abnormalities, microbiome in the gut-skin axis also contributes for the progression of AD. The alteration in gut flora results in dysbiosis, an imbalance within natural microbiota which causes many health complications including AD. Probiotics are live microorganisms which support gut microbiota and elicit several health benefits when consumed. However, viability and stability of probiotics are the major concerns for their effective usage. Probiotics are available in various conventional dosage forms like tablet, capsules, sachets, oral liquids, etc. Additionally, they are also incorporated into controlled delivery systems using microencapsulation and lyophilization techniques which not only deliver required amount of probiotic at a targeted site but also significantly improve their sustainability. At present, several clinical trials are ongoing for different strains of probiotics and their relevance to microbiota. In the future, new routes and dosage forms can be explored for effective delivery of probiotics in management of AD.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literatur
Zurück zum Zitat Akdis M (2006) Healthy immune response to allergens: T regulatory cells and more. Curr Opin Immunol 18(6):738–744PubMed Akdis M (2006) Healthy immune response to allergens: T regulatory cells and more. Curr Opin Immunol 18(6):738–744PubMed
Zurück zum Zitat Arndt J, Smith N, Tausk F (2008) Stress and atopic dermatitis. Curr Allergy Asthma Rep 8(4):312–317PubMed Arndt J, Smith N, Tausk F (2008) Stress and atopic dermatitis. Curr Allergy Asthma Rep 8(4):312–317PubMed
Zurück zum Zitat Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI (2005) Host-bacterial mutualism in the human intestine. Science 307(5717):1915–1920PubMed Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI (2005) Host-bacterial mutualism in the human intestine. Science 307(5717):1915–1920PubMed
Zurück zum Zitat Barbarot S, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson EL et al (2018) Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy 73(6):1284–1293PubMed Barbarot S, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson EL et al (2018) Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy 73(6):1284–1293PubMed
Zurück zum Zitat Barton SJ, Ngo S, Costello P, Garratt E, El-Heis S, Antoun E et al (2017) DNA methylation of Th2 lineage determination genes at birth is associated with allergic outcomes in childhood. Clin Exp Allergy 47(12):1599–1608PubMedPubMedCentral Barton SJ, Ngo S, Costello P, Garratt E, El-Heis S, Antoun E et al (2017) DNA methylation of Th2 lineage determination genes at birth is associated with allergic outcomes in childhood. Clin Exp Allergy 47(12):1599–1608PubMedPubMedCentral
Zurück zum Zitat Berke R, Singh A, Guralnick M (2012) Atopic dermatitis: an overview. Am Fam Physician 86(1):35–42PubMed Berke R, Singh A, Guralnick M (2012) Atopic dermatitis: an overview. Am Fam Physician 86(1):35–42PubMed
Zurück zum Zitat Braham SJ, Pugashetti R, Koo J, Maibach HI (2010) Occlusive therapy in atopic dermatitis: overview. J Dermatolog Treat 21:62–72PubMed Braham SJ, Pugashetti R, Koo J, Maibach HI (2010) Occlusive therapy in atopic dermatitis: overview. J Dermatolog Treat 21:62–72PubMed
Zurück zum Zitat Byrd AL, Deming C, Cassidy SKB et al (2017) Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis. Sci Transl Med 9(397):eaal4651PubMedPubMedCentral Byrd AL, Deming C, Cassidy SKB et al (2017) Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis. Sci Transl Med 9(397):eaal4651PubMedPubMedCentral
Zurück zum Zitat Chamlin SL, Frieden IJ, Fowler A, Williams M, Kao J, Sheu M, Elias PM (2001) Ceramide-dominant, barrier-repair lipids improve childhood atopic dermatitis. Arch Dermatol 137(8):1110–1112PubMed Chamlin SL, Frieden IJ, Fowler A, Williams M, Kao J, Sheu M, Elias PM (2001) Ceramide-dominant, barrier-repair lipids improve childhood atopic dermatitis. Arch Dermatol 137(8):1110–1112PubMed
Zurück zum Zitat Champagne CP, Møllgaard H (2008) Production of probiotic cultures and their addition in fermented foods. In: Handbook of fermented functional foods, Second Edition. CRC Press, Boca Raton Champagne CP, Møllgaard H (2008) Production of probiotic cultures and their addition in fermented foods. In: Handbook of fermented functional foods, Second Edition. CRC Press, Boca Raton
Zurück zum Zitat Cook MT, Tzortzis G, Charalampopoulos D, Khutoryanskiy VV (2011) Production and evaluation of dry alginate–chitosan microcapsules as an enteric delivery vehicle for probiotic bacteria. Biomacromolecules 12:2834–2840PubMed Cook MT, Tzortzis G, Charalampopoulos D, Khutoryanskiy VV (2011) Production and evaluation of dry alginate–chitosan microcapsules as an enteric delivery vehicle for probiotic bacteria. Biomacromolecules 12:2834–2840PubMed
Zurück zum Zitat Cook MT, Tzortzis G, Charalampopoulos D, Khutoryanskiy VV (2012) Microencapsulation of probiotics for gastrointestinal delivery. J Control Release 162(1):56–67PubMed Cook MT, Tzortzis G, Charalampopoulos D, Khutoryanskiy VV (2012) Microencapsulation of probiotics for gastrointestinal delivery. J Control Release 162(1):56–67PubMed
Zurück zum Zitat Darsow U, Wollenberg A, Simon D, Taïeb A, Werfel T, Oranje A et al (2010) ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 24(3):317–328PubMed Darsow U, Wollenberg A, Simon D, Taïeb A, Werfel T, Oranje A et al (2010) ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 24(3):317–328PubMed
Zurück zum Zitat De Vuyst L (2000) Technology aspects related to the application of functional starter cultures. Food Technol Biotechnol 38(1):105–112 De Vuyst L (2000) Technology aspects related to the application of functional starter cultures. Food Technol Biotechnol 38(1):105–112
Zurück zum Zitat Devillers AC, Oranje AP (2012) Wet-wrap treatment in children with atopic dermatitis: a practical guideline. Pediatr Dermatol 29(1):24–27PubMed Devillers AC, Oranje AP (2012) Wet-wrap treatment in children with atopic dermatitis: a practical guideline. Pediatr Dermatol 29(1):24–27PubMed
Zurück zum Zitat Devillers ACA, De Waard-van der Spek FB, Mulder PGH, Oranje AP (2002) Treatment of refractory atopic dermatitis using ‘wet-wrap’ dressings and diluted corticosteroids: results of standardized treatment in both children and adults. Dermatology 204(1):50–55PubMed Devillers ACA, De Waard-van der Spek FB, Mulder PGH, Oranje AP (2002) Treatment of refractory atopic dermatitis using ‘wet-wrap’ dressings and diluted corticosteroids: results of standardized treatment in both children and adults. Dermatology 204(1):50–55PubMed
Zurück zum Zitat Ding WK, Shah NP (2009) An improved method of microencapsulation of probiotic bacteria for their stability in acidic and bile conditions during storage. J Food Sci 74(2):M53–M61PubMed Ding WK, Shah NP (2009) An improved method of microencapsulation of probiotic bacteria for their stability in acidic and bile conditions during storage. J Food Sci 74(2):M53–M61PubMed
Zurück zum Zitat Eberlein B, Eicke C, Reinhardt HW, Ring J (2008) Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study). J Eur Acad Dermatol Venereol 22(1):73–82PubMed Eberlein B, Eicke C, Reinhardt HW, Ring J (2008) Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study). J Eur Acad Dermatol Venereol 22(1):73–82PubMed
Zurück zum Zitat Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M et al (1998) Trends in alternative medicine use in the United States. J Am Med Assoc 280:1569–1575 Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M et al (1998) Trends in alternative medicine use in the United States. J Am Med Assoc 280:1569–1575
Zurück zum Zitat Farid R, Ahanchian H, Jabbari F, Moghiman T (2011) Effect of a new synbiotic mixture on atopic dermatitis in children: a randomized-controlled trial. Iran J Pediatr 21(2):225PubMedPubMedCentral Farid R, Ahanchian H, Jabbari F, Moghiman T (2011) Effect of a new synbiotic mixture on atopic dermatitis in children: a randomized-controlled trial. Iran J Pediatr 21(2):225PubMedPubMedCentral
Zurück zum Zitat Fujimura KE, Sitarik AR, Havstad S, Lin DL, Levan S, Fadrosh D et al (2016) Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat Med 22(10):1187PubMedPubMedCentral Fujimura KE, Sitarik AR, Havstad S, Lin DL, Levan S, Fadrosh D et al (2016) Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat Med 22(10):1187PubMedPubMedCentral
Zurück zum Zitat Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D et al (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504(7480):446PubMed Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D et al (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504(7480):446PubMed
Zurück zum Zitat Gaspar NK, Aidé MK (2016) Atopic dermatitis: allergic dermatitis or neuroimmune dermatitis? An Bras Dermatol 91(4):479–488PubMedPubMedCentral Gaspar NK, Aidé MK (2016) Atopic dermatitis: allergic dermatitis or neuroimmune dermatitis? An Bras Dermatol 91(4):479–488PubMedPubMedCentral
Zurück zum Zitat Gisondi P, Girolomoni G (2016) Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis. Drug Des Devel Ther 10:1763PubMedPubMedCentral Gisondi P, Girolomoni G (2016) Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis. Drug Des Devel Ther 10:1763PubMedPubMedCentral
Zurück zum Zitat Gooderham MJ et al (2018) Dupilumab: a review of its use in the treatment of atopic dermatitis. J Am Acad Dermatol 78(3):S28–S36PubMed Gooderham MJ et al (2018) Dupilumab: a review of its use in the treatment of atopic dermatitis. J Am Acad Dermatol 78(3):S28–S36PubMed
Zurück zum Zitat Gschwandtner M, Mildner M, Mlitz V, Gruber F, Eckhart L, Werfel T et al (2013) Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model. Allergy 68(1):37–47PubMed Gschwandtner M, Mildner M, Mlitz V, Gruber F, Eckhart L, Werfel T et al (2013) Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model. Allergy 68(1):37–47PubMed
Zurück zum Zitat Guéniche A, Hennino A, Goujon C, Dahel K, Bastien P, Martin R et al (2006) Improvement of atopic dermatitis skin symptoms by Vitreoscilla filiformis bacterial extract. Eur J Dermatol 16(4):380–384PubMed Guéniche A, Hennino A, Goujon C, Dahel K, Bastien P, Martin R et al (2006) Improvement of atopic dermatitis skin symptoms by Vitreoscilla filiformis bacterial extract. Eur J Dermatol 16(4):380–384PubMed
Zurück zum Zitat Harper JI, Ahmed I, Barclay G, Lacour M, Hoeger P, Cork MJ et al (2000) Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol 142(1):52–58PubMed Harper JI, Ahmed I, Barclay G, Lacour M, Hoeger P, Cork MJ et al (2000) Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol 142(1):52–58PubMed
Zurück zum Zitat Hedman-Lagerlöf E, Bergman A, Lindefors N, Bradley M (2019) Exposure-based cognitive behavior therapy for atopic dermatitis: an open trial. Cogn Behav Ther 48(4):300–310PubMed Hedman-Lagerlöf E, Bergman A, Lindefors N, Bradley M (2019) Exposure-based cognitive behavior therapy for atopic dermatitis: an open trial. Cogn Behav Ther 48(4):300–310PubMed
Zurück zum Zitat Heine G, Hoefer N, Franke A, Nöthling U, Schumann RR, Hamann L, Worm M (2013) Association of vitamin D receptor gene polymorphisms with severe atopic dermatitis in adults. Br J Dermatol 168(4):855–858PubMed Heine G, Hoefer N, Franke A, Nöthling U, Schumann RR, Hamann L, Worm M (2013) Association of vitamin D receptor gene polymorphisms with severe atopic dermatitis in adults. Br J Dermatol 168(4):855–858PubMed
Zurück zum Zitat Henry E, Li X-m (2016) Traditional Chinese medicine, Western science, and the fight against allergic disease. World Scientific, Singapore Henry E, Li X-m (2016) Traditional Chinese medicine, Western science, and the fight against allergic disease. World Scientific, Singapore
Zurück zum Zitat Hoare C, Po ALW, Williams H (2000) Systematic review of treatments for atopic eczema. Health Technol Assess 4(37):1–191PubMedPubMedCentral Hoare C, Po ALW, Williams H (2000) Systematic review of treatments for atopic eczema. Health Technol Assess 4(37):1–191PubMedPubMedCentral
Zurück zum Zitat Hood SK, Zottola EA (1988) Effect of low pH on the ability of Lactobacillus-acidophilus to survive and adhere to human intestinal cells. J Food Sci 53(5):1514–1516 Hood SK, Zottola EA (1988) Effect of low pH on the ability of Lactobacillus-acidophilus to survive and adhere to human intestinal cells. J Food Sci 53(5):1514–1516
Zurück zum Zitat Horne DJ, White AE, Varigos GA (1989) A preliminary study of psychological therapy in the management of atopic eczema. Br J Med Psychol 62(3):241–248PubMed Horne DJ, White AE, Varigos GA (1989) A preliminary study of psychological therapy in the management of atopic eczema. Br J Med Psychol 62(3):241–248PubMed
Zurück zum Zitat Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS (2009) Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 123(5):e808–e814PubMed Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS (2009) Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 123(5):e808–e814PubMed
Zurück zum Zitat Inoue Y, Kambara T, Murata N, Komori-Yamaguchi J, Matsukura S, Takahashi Y et al (2014) Effects of oral administration of lactobacillus acidophilus l-92 on the symptoms and serum cytokines of atopic dermatitis in Japanese adults: a double-blind, randomized, clinical trial. Int Arch Allergy Immunol 165(4):247–254. https://doi.org/10.1159/000369806CrossRefPubMed Inoue Y, Kambara T, Murata N, Komori-Yamaguchi J, Matsukura S, Takahashi Y et al (2014) Effects of oral administration of lactobacillus acidophilus l-92 on the symptoms and serum cytokines of atopic dermatitis in Japanese adults: a double-blind, randomized, clinical trial. Int Arch Allergy Immunol 165(4):247–254. https://​doi.​org/​10.​1159/​000369806CrossRefPubMed
Zurück zum Zitat Jariwala SP, Abrams E, Benson A, Fodeman J, Zheng T (2011) The role of thymic stromal lymphopoietin in the immunopathogenesis of atopic dermatitis. Clin Exp Allergy 41(11):1515–1520PubMed Jariwala SP, Abrams E, Benson A, Fodeman J, Zheng T (2011) The role of thymic stromal lymphopoietin in the immunopathogenesis of atopic dermatitis. Clin Exp Allergy 41(11):1515–1520PubMed
Zurück zum Zitat Kalamaha K, Reis E, Newton S, Roche C, Julson J, Fernandes H, Rodrigues J (2019) Atopic dermatitis: a review of evolving targeted therapies. Expert Rev Clin Immunol 15(3):275–288PubMed Kalamaha K, Reis E, Newton S, Roche C, Julson J, Fernandes H, Rodrigues J (2019) Atopic dermatitis: a review of evolving targeted therapies. Expert Rev Clin Immunol 15(3):275–288PubMed
Zurück zum Zitat Kaufman BP, Guttman-Yassky E, Alexis AF (2018) Atopic dermatitis in diverse racial and ethnic groups—variations in epidemiology, genetics, clinical presentation and treatment. Exp Dermatol 27(4):340–357PubMed Kaufman BP, Guttman-Yassky E, Alexis AF (2018) Atopic dermatitis in diverse racial and ethnic groups—variations in epidemiology, genetics, clinical presentation and treatment. Exp Dermatol 27(4):340–357PubMed
Zurück zum Zitat Kim SJ, Cho SY, Kim SH, Song OJ, Shin IS, Cha DS, Park HJ (2008) Effect of microencapsulation on viability and other characteristics in Lactobacillus acidophilus ATCC 43121. LWT Food Sci Technol 41(3):493–500 Kim SJ, Cho SY, Kim SH, Song OJ, Shin IS, Cha DS, Park HJ (2008) Effect of microencapsulation on viability and other characteristics in Lactobacillus acidophilus ATCC 43121. LWT Food Sci Technol 41(3):493–500
Zurück zum Zitat Kim J, Kim BE, Leung DYM (2019a) Pathophysiology of atopic dermatitis: clinical implications. Allergy Asthma Proc 40(2):84–92PubMedPubMedCentral Kim J, Kim BE, Leung DYM (2019a) Pathophysiology of atopic dermatitis: clinical implications. Allergy Asthma Proc 40(2):84–92PubMedPubMedCentral
Zurück zum Zitat Kircik LH (2012) Efficacy and tolerability of retapamulin 1% ointment for the treatment of infected atopic dermatitis: a pilot study. J Drugs Dermatol 11(7):858–860PubMed Kircik LH (2012) Efficacy and tolerability of retapamulin 1% ointment for the treatment of infected atopic dermatitis: a pilot study. J Drugs Dermatol 11(7):858–860PubMed
Zurück zum Zitat Larsen FS, Hanifin J (2002) Epidemiology of atopic dermatitis. Immunol Allergy Clin N Am 22(1):1–24 Larsen FS, Hanifin J (2002) Epidemiology of atopic dermatitis. Immunol Allergy Clin N Am 22(1):1–24
Zurück zum Zitat Lee NY, Ibrahim O, Khetarpal S, Gaber M, Jamas S, Gryllos I, Dover JS (2018) Dermal microflora restoration with ammonia-oxidizing bacteria Nitrosomonas Eutropha in the treatment of keratosis pilaris: a randomized clinical trial. J Drugs Dermatol 17(3):285–288PubMed Lee NY, Ibrahim O, Khetarpal S, Gaber M, Jamas S, Gryllos I, Dover JS (2018) Dermal microflora restoration with ammonia-oxidizing bacteria Nitrosomonas Eutropha in the treatment of keratosis pilaris: a randomized clinical trial. J Drugs Dermatol 17(3):285–288PubMed
Zurück zum Zitat Leonardi S, Cuppari C, Manti S, Filippelli M, Parisi GF, Borgia F et al (2015) Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): association with clinical severity and phenotype. Allergy Asthma Proc 36(1):74–81PubMed Leonardi S, Cuppari C, Manti S, Filippelli M, Parisi GF, Borgia F et al (2015) Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): association with clinical severity and phenotype. Allergy Asthma Proc 36(1):74–81PubMed
Zurück zum Zitat Liu HN, Wong CK (1997) In vitro immunosuppressive effects of methotrexate and azathioprine on Langerhans cells. Arch Dermatol Res 289(2):94–97PubMed Liu HN, Wong CK (1997) In vitro immunosuppressive effects of methotrexate and azathioprine on Langerhans cells. Arch Dermatol Res 289(2):94–97PubMed
Zurück zum Zitat Luger T, De Raeve L, Gelmetti C, Kakourou T, Katsarou A, Lambert J et al (2013) Recommendations for pimecrolimus 1% cream in the treatment of mild-to-moderate atopic dermatitis: from medical needs to a new treatment algorithm. Eur J Dermatol 23(6):758–766PubMed Luger T, De Raeve L, Gelmetti C, Kakourou T, Katsarou A, Lambert J et al (2013) Recommendations for pimecrolimus 1% cream in the treatment of mild-to-moderate atopic dermatitis: from medical needs to a new treatment algorithm. Eur J Dermatol 23(6):758–766PubMed
Zurück zum Zitat Medzhitov R, Janeway CA (2002) Decoding the patterns of self and nonself by the innate immune system. Science 296(5566):298–300PubMed Medzhitov R, Janeway CA (2002) Decoding the patterns of self and nonself by the innate immune system. Science 296(5566):298–300PubMed
Zurück zum Zitat Meng J, Moriyama M, Feld M, Buddenkotte J, Buhl T, Szöllösi A et al (2018) New mechanism underlying IL-31–induced atopic dermatitis. J Allergy Clin Immunol 141(5):1677–1689PubMed Meng J, Moriyama M, Feld M, Buddenkotte J, Buhl T, Szöllösi A et al (2018) New mechanism underlying IL-31–induced atopic dermatitis. J Allergy Clin Immunol 141(5):1677–1689PubMed
Zurück zum Zitat Moyle M, Cevikbas F, Harden JL, Guttman-Yassky E (2019) Understanding the immune landscape in atopic dermatitis: the era of biologics and emerging therapeutic approaches. Exp Dermatol 28(7):756–768PubMedPubMedCentral Moyle M, Cevikbas F, Harden JL, Guttman-Yassky E (2019) Understanding the immune landscape in atopic dermatitis: the era of biologics and emerging therapeutic approaches. Exp Dermatol 28(7):756–768PubMedPubMedCentral
Zurück zum Zitat Nowicki R, Trzeciak M, Wilkowska A, Sokołowska-Wojdyło M, Ługowska-Umer H, Barańska-Rybak W et al (2015) Atopic dermatitis: current treatment guidelines. Statement of the experts of the Dermatological Section, Polish Society of Allergology, and the Allergology Section, Polish Society of Dermatology. Adv Dermatol Allergology 32(4):239 Nowicki R, Trzeciak M, Wilkowska A, Sokołowska-Wojdyło M, Ługowska-Umer H, Barańska-Rybak W et al (2015) Atopic dermatitis: current treatment guidelines. Statement of the experts of the Dermatological Section, Polish Society of Allergology, and the Allergology Section, Polish Society of Dermatology. Adv Dermatol Allergology 32(4):239
Zurück zum Zitat Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI, ISAAC Phase Three Study Group (2009) Global variations in prevalence of eczema symptoms in children from ISAAC phase three. J Allergy Clin Immunol 124(6):1251–1258PubMed Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI, ISAAC Phase Three Study Group (2009) Global variations in prevalence of eczema symptoms in children from ISAAC phase three. J Allergy Clin Immunol 124(6):1251–1258PubMed
Zurück zum Zitat O’Regan GM, Sandilands A, McLean WI, Irvine AD (2008) Filaggrin in atopic dermatitis. J Allergy Clin Immunol 122(4):689–693PubMed O’Regan GM, Sandilands A, McLean WI, Irvine AD (2008) Filaggrin in atopic dermatitis. J Allergy Clin Immunol 122(4):689–693PubMed
Zurück zum Zitat Oren E, Banerji A, Camargo CA (2008) Vitamin D and atopic disorders in an obese population screened for vitamin D deficiency. J Allergy Clin Immunol 121(2):533PubMed Oren E, Banerji A, Camargo CA (2008) Vitamin D and atopic disorders in an obese population screened for vitamin D deficiency. J Allergy Clin Immunol 121(2):533PubMed
Zurück zum Zitat Paller AS, Tom WL, Lebwohl MG, Blumenthal RL, Boguniewicz M, Call RS et al (2016) Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol 75(3):494–503PubMed Paller AS, Tom WL, Lebwohl MG, Blumenthal RL, Boguniewicz M, Call RS et al (2016) Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol 75(3):494–503PubMed
Zurück zum Zitat Penders J, Thijs C, van den Brandt PA, Kummeling I, Snijders B, Stelma F et al (2007) Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 56(5):661–667PubMed Penders J, Thijs C, van den Brandt PA, Kummeling I, Snijders B, Stelma F et al (2007) Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 56(5):661–667PubMed
Zurück zum Zitat Pité H (2010) Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium Lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Revista Portuguesa de Imunoalergologia 18:385–386 Pité H (2010) Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium Lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Revista Portuguesa de Imunoalergologia 18:385–386
Zurück zum Zitat Product Summary (2007) Summary of product characteristics; harm; methotrexate – ebewe – tablets – 3.12.2007 Product Summary (2007) Summary of product characteristics; harm; methotrexate – ebewe – tablets – 3.12.2007
Zurück zum Zitat Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C et al (2012) Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol 26(8):1045–1060PubMed Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C et al (2012) Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol 26(8):1045–1060PubMed
Zurück zum Zitat Roekevisch E, Spuls PI, Kuester D, Limpens J, Schmitt J (2014) Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review. J Allergy Clin Immunol 133(2):429–438PubMed Roekevisch E, Spuls PI, Kuester D, Limpens J, Schmitt J (2014) Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review. J Allergy Clin Immunol 133(2):429–438PubMed
Zurück zum Zitat Rosignoli C, Thibaut de Ménonville S, Orfila D, Béal M, Bertino B, Aubert J et al (2018) A topical treatment containing heat-treated Lactobacillus johnsonii NCC 533 reduces Staphylococcus aureus adhesion and induces antimicrobial peptide expression in an in vitro reconstructed human epidermis model. Exp Dermatol 27(4):358–365. https://doi.org/10.1111/exd.13504CrossRefPubMed Rosignoli C, Thibaut de Ménonville S, Orfila D, Béal M, Bertino B, Aubert J et al (2018) A topical treatment containing heat-treated Lactobacillus johnsonii NCC 533 reduces Staphylococcus aureus adhesion and induces antimicrobial peptide expression in an in vitro reconstructed human epidermis model. Exp Dermatol 27(4):358–365. https://​doi.​org/​10.​1111/​exd.​13504CrossRefPubMed
Zurück zum Zitat Round JL, Mazmanian SK (2010) Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci 107(27):12204–12209PubMedPubMedCentral Round JL, Mazmanian SK (2010) Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci 107(27):12204–12209PubMedPubMedCentral
Zurück zum Zitat Samuelov L, Sprecher E (2014) Peeling off the genetics of atopic dermatitis–like congenital disorders. J Allergy Clin Immunol 134(4):808–815PubMed Samuelov L, Sprecher E (2014) Peeling off the genetics of atopic dermatitis–like congenital disorders. J Allergy Clin Immunol 134(4):808–815PubMed
Zurück zum Zitat Sarti MG (1998) Biofeedback in dermatology. Clin Dermatol 16(6):711–714PubMed Sarti MG (1998) Biofeedback in dermatology. Clin Dermatol 16(6):711–714PubMed
Zurück zum Zitat Schmitt J, von Kobyletzki L, Svensson Å, Apfelbacher C (2011) Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials. Br J Dermatol 164(2):415–428PubMed Schmitt J, von Kobyletzki L, Svensson Å, Apfelbacher C (2011) Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials. Br J Dermatol 164(2):415–428PubMed
Zurück zum Zitat Schwarz A, Bruhs A, Schwarz T (2017) The short-chain fatty acid sodium butyrate functions as a regulator of the skin immune system. J Investig Dermatol 137(4):855–864PubMed Schwarz A, Bruhs A, Schwarz T (2017) The short-chain fatty acid sodium butyrate functions as a regulator of the skin immune system. J Investig Dermatol 137(4):855–864PubMed
Zurück zum Zitat Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, Bergman JN et al (2014) Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol 71(2):327–349PubMedPubMedCentral Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, Bergman JN et al (2014) Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol 71(2):327–349PubMedPubMedCentral
Zurück zum Zitat Simons FER (1999) Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis. J Allergy Clin Immunol 104(2):433–440PubMed Simons FER (1999) Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis. J Allergy Clin Immunol 104(2):433–440PubMed
Zurück zum Zitat Simons FER, Early Prevention of Asthma in Atopic Children (EPAAC) Study Group (2007) Safety of levocetirizine treatment in young atopic children: an 18-month study. Pediatr Allergy Immunol 18(6):535–542PubMed Simons FER, Early Prevention of Asthma in Atopic Children (EPAAC) Study Group (2007) Safety of levocetirizine treatment in young atopic children: an 18-month study. Pediatr Allergy Immunol 18(6):535–542PubMed
Zurück zum Zitat Smits HH, Engering A, Van Der Kleij D, De Jong EC, Schipper K, Van Capel TMM et al (2005) Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 115(6):1260–1267. https://doi.org/10.1016/j.jaci.2005.03.036CrossRefPubMed Smits HH, Engering A, Van Der Kleij D, De Jong EC, Schipper K, Van Capel TMM et al (2005) Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 115(6):1260–1267. https://​doi.​org/​10.​1016/​j.​jaci.​2005.​03.​036CrossRefPubMed
Zurück zum Zitat Solanki HK, Pawar DD, Shah DA, Prajapati VD, Jani GK, Mulla AM, Thakar PM (2013) Development of microencapsulation delivery system for long-term preservation of probiotics as biotherapeutics agent. BioMed Res Int 2013:620719PubMedPubMedCentral Solanki HK, Pawar DD, Shah DA, Prajapati VD, Jani GK, Mulla AM, Thakar PM (2013) Development of microencapsulation delivery system for long-term preservation of probiotics as biotherapeutics agent. BioMed Res Int 2013:620719PubMedPubMedCentral
Zurück zum Zitat Takizawa T, Morikawa A, Arakawa H (2018) Epidemiology of atopic dermatitis in Japan, Evolution of atopic dermatitis in the 21st century. Springer, Singapore, pp 13–24 Takizawa T, Morikawa A, Arakawa H (2018) Epidemiology of atopic dermatitis in Japan, Evolution of atopic dermatitis in the 21st century. Springer, Singapore, pp 13–24
Zurück zum Zitat Talwalkar A, Kailasapathy K (2004) The role of oxygen in the viability of probiotic bacteria with reference to L. acidophilus and Bifidobacterium spp. Curr Issues Intest Microbiol 5(1):1–8PubMed Talwalkar A, Kailasapathy K (2004) The role of oxygen in the viability of probiotic bacteria with reference to L. acidophilus and Bifidobacterium spp. Curr Issues Intest Microbiol 5(1):1–8PubMed
Zurück zum Zitat Tamime AY, Saarela M, Sondergaard AK, Mistry VV, Shah NP (2005) Production and maintenance of viability of probiotic microorganisms in dairy products. In: Probiotic dairy products. Blackwell, Hoboken Tamime AY, Saarela M, Sondergaard AK, Mistry VV, Shah NP (2005) Production and maintenance of viability of probiotic microorganisms in dairy products. In: Probiotic dairy products. Blackwell, Hoboken
Zurück zum Zitat Tan Q, Yang H, Liu E, Wang H (2017) P38/ERK MAPK signaling pathways are involved in the regulation of filaggrin and involucrin by IL 17. Mol Med Rep 16(6):8863–8867PubMedPubMedCentral Tan Q, Yang H, Liu E, Wang H (2017) P38/ERK MAPK signaling pathways are involved in the regulation of filaggrin and involucrin by IL 17. Mol Med Rep 16(6):8863–8867PubMedPubMedCentral
Zurück zum Zitat Thum D, Seidl HP, Hein R, Ring J, Andres C, Mempel M (2013) Current resistance patterns of Staphylococcus aureus towards topical antibiotics and relevant antiseptics in patients with atopic dermatitis and impetigo. JDDG 11(9):875–878PubMed Thum D, Seidl HP, Hein R, Ring J, Andres C, Mempel M (2013) Current resistance patterns of Staphylococcus aureus towards topical antibiotics and relevant antiseptics in patients with atopic dermatitis and impetigo. JDDG 11(9):875–878PubMed
Zurück zum Zitat Thyssen JP, Kezic S (2014) Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol 134(4):792–799PubMed Thyssen JP, Kezic S (2014) Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol 134(4):792–799PubMed
Zurück zum Zitat Toda M, Leung DY, Molet S, Boguniewicz M, Taha R, Christodoulopoulos P et al (2003) Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol 111(4):875–881PubMed Toda M, Leung DY, Molet S, Boguniewicz M, Taha R, Christodoulopoulos P et al (2003) Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol 111(4):875–881PubMed
Zurück zum Zitat Ueno N, Fujiya M, Segawa S, Nata T, Moriichi K, Tanabe H et al (2011) Heat-killed body of lactobacillus brevis SBC8803 ameliorates intestinal injury in a murine model of colitis by enhancing the intestinal barrier function. Inflamm Bowel Dis 17(11):2235–2250. https://doi.org/10.1002/ibd.21597CrossRefPubMed Ueno N, Fujiya M, Segawa S, Nata T, Moriichi K, Tanabe H et al (2011) Heat-killed body of lactobacillus brevis SBC8803 ameliorates intestinal injury in a murine model of colitis by enhancing the intestinal barrier function. Inflamm Bowel Dis 17(11):2235–2250. https://​doi.​org/​10.​1002/​ibd.​21597CrossRefPubMed
Zurück zum Zitat Watanabe S, Narisawa Y, Arase S, Okamatsu H, Ikenaga T, Tajiri Y, Kumemura M (2003) Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol 111(3):587–591PubMed Watanabe S, Narisawa Y, Arase S, Okamatsu H, Ikenaga T, Tajiri Y, Kumemura M (2003) Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol 111(3):587–591PubMed
Zurück zum Zitat Weiland SK, Björkstén B, Brunekreef B, Cookson WOC, Von Mutius E, Strachan DP (2004) Phase II of the international study of asthma and allergies in childhood (ISAAC II): rationale and methods. Eur Respir J 24(3):406–412PubMed Weiland SK, Björkstén B, Brunekreef B, Cookson WOC, Von Mutius E, Strachan DP (2004) Phase II of the international study of asthma and allergies in childhood (ISAAC II): rationale and methods. Eur Respir J 24(3):406–412PubMed
Zurück zum Zitat Werfel T, Kapp A (2002) T-cells in atopic dermatitis. In: Leung D, Bieber T (eds) Atopic dermatitis. Marcel Decker, St. Louis, pp 241–266 Werfel T, Kapp A (2002) T-cells in atopic dermatitis. In: Leung D, Bieber T (eds) Atopic dermatitis. Marcel Decker, St. Louis, pp 241–266
Zurück zum Zitat Williams H, Robertson C, Stewart A, Aït-Khaled N, Anabwani G, Anderson R et al (1999) Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 103(1):125–138PubMed Williams H, Robertson C, Stewart A, Aït-Khaled N, Anabwani G, Anderson R et al (1999) Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 103(1):125–138PubMed
Zurück zum Zitat Witte W (2000) Ecological impact of antibiotic use in animals on different complex microflora: environment. Int J Antimicrob Agents 14(4):321–325PubMed Witte W (2000) Ecological impact of antibiotic use in animals on different complex microflora: environment. Int J Antimicrob Agents 14(4):321–325PubMed
Zurück zum Zitat Yeşilova Y, Çalka Ö, Akdeniz N, Berktaş M (2012) Effect of probiotics on the treatment of children with atopic dermatitis. Ann Dermatol 24(2):189–193PubMedPubMedCentral Yeşilova Y, Çalka Ö, Akdeniz N, Berktaş M (2012) Effect of probiotics on the treatment of children with atopic dermatitis. Ann Dermatol 24(2):189–193PubMedPubMedCentral
Zurück zum Zitat Yim JH, Kim DH, Ku JK, Kang YS, Kim MY, Kim HO et al (2006) Therapeutic effects of probiotics in patients with atopic dermatitis. J Microbiol Biotechnol 16(11):1699–1705 Yim JH, Kim DH, Ku JK, Kang YS, Kim MY, Kim HO et al (2006) Therapeutic effects of probiotics in patients with atopic dermatitis. J Microbiol Biotechnol 16(11):1699–1705
Zurück zum Zitat Yoshida Y, Seki T, Matsunaka H, Watanabe T, Shindo M, Yamada N, Yamamoto O (2010) Clinical effects of probiotic bifidobacterium breve supplementation in adult patients with atopic dermatitis. Yonago Acta Med 53(2):37–45 Yoshida Y, Seki T, Matsunaka H, Watanabe T, Shindo M, Yamada N, Yamamoto O (2010) Clinical effects of probiotic bifidobacterium breve supplementation in adult patients with atopic dermatitis. Yonago Acta Med 53(2):37–45
Metadaten
Titel
Probiotics for Atopic Dermatitis: An Update
verfasst von
Pratik Kakade
Sarika Wairkar
Shruti Lohakare
Purav Shah
Vandana Patravale
Copyright-Jahr
2022
Verlag
Springer Singapore
DOI
https://doi.org/10.1007/978-981-16-5628-6_9